Dave Fornell, ITN Editor

Dave Fornell is the editor of Diagnostic & Interventional Cardiology magazine and assistant editor for Imaging Technology News magazine.

Blog | Dave Fornell, ITN Editor | September 03, 2014

Future Cardiovascular CT Advances to Watch

As technology continues to advance for all diagnostic imaging modalities, it sometimes reminds me of a race between vendors to build a better mouse trap. The main issue between cardiac echo, computed tomography (CT), magnetic resonance imaging (MRI), nuclear (SPECT and PET) and invasive angiography is that each has its strengths and weaknesses. When one test falls short, another is used to add diagnostic information, but it also adds time and cost. Unfortunately, in this era of cutting costs and bundled payments, the holy grail of medical imaging would be a one-stop shop cardiac imaging test that combines the majority of the key assets of each of these modalities.

I attended the Society of Cardiovascular Computed Tomography (SCCT) annual meeting in July, where both cardiologists and radiologists came together to make a case for why CT will become the primary cardiac imaging test in coming years. It showed CT radiation is declining and new technology can bring cardiac CT doses below 1 mSv, which is key to CT’s wider acceptance. Data from several trials demonstrate the viability of CT to accurately show myocardial perfusion and fractional flow reserve (FFR) data for the entire coronary tree from a single scan. Work is also continuing to improve plaque characterization software to bring it on par with invasive catheter-based virtual histology intravascular ultrasound (VH-IVUS) or spectrographic plaque analysis. Additionally, spectral CT imaging may enable a new way to image chemical makeup of tissue and allow new types of contrast media. 

Speakers at SCCT discussed the use of gold nanoparticles with a polyethylene glycol (PEG) coating, or tantalum, as replacement agents for iodine blood imaging; bromide and fluorine with a phospholipid coating to image liver tumors; and iodine-loaded or bismuth nanoparticles with a biomarker to target fibrin to clearly image blood clots. Nanoparticles may also boost the ability of iodine as a contrast agent. By coating iodine inside liposome particles, the outer shell will protect the iodine from breaking down immediately, both extending its imaging half-life and possibly aiding renal clearance over a longer period of time to reduce contrast-induced nephropathy (CIN). 

New types of contrast, especially if combined with spectral CT, may enable inflammation and macrophage imaging, both components of vulnerable plaque. If validated, this new way to image vulnerable plaques prior to rupture might offer a novel way to determine heart attack risk and possibly identify lesions to stent before a heart attack occurs.  

To read more on these and other cardiac CT advances, see the article from the September-October 2014 issue of DAIC. 

Watch a video interview regarding these advances in cardiac CT.

Related Content

Median Technologies and the Nice University Hospital to Use AI in Lung Cancer Screening
News | Artificial Intelligence | March 15, 2018
March 15, 2018 – Median Technologies, the industry-leading Imaging Phenomics Company and the Nice University Hospital
Siemens Healthineers Launches New Partners for Digital Ecosystem at HIMSS 2018
News | PACS Accessories | March 12, 2018
At the 2018 Healthcare Information and Management Systems Society (HIMSS) Annual Conference and Exhibition, March 5-9...
Designed to optimize workflow, IntelliSpace Portal supports consistency across applications.
Sponsored Content | Case Study | Imaging | March 06, 2018
As one of the largest Catholic, not-for-profit healthcare systems in the United States, St. Louis-based SSM Health has...
TriHealth in Cincinnati

TriHealth in Cincinnati.

Sponsored Content | Case Study | Contrast Media Injectors | March 06, 2018
The continuing search for advantages to improve workflow has radiology departments constantly searching for new...
Carestream Supplies Wireless Digital X-ray Detectors for 2018 NFL Combine
News | Digital Radiography (DR) | February 27, 2018
In addition to demonstrating their speed, agility and strength at the 2018 National Football League (NFL) Scouting...
Mirada Medical Releases DLCExpert for Radiotherapy Treatment Planning
Technology | Treatment Planning | February 22, 2018
February 22, 2018 — U.K.-based medical imaging software provider Mirada Medical has released DLCExpert, the first com
Aidoc Introduces AI Solution for Whole-Body CT Scan Analysis
News | Artificial Intelligence | February 20, 2018
Deep learning startup company Aidoc announced what it calls the world’s first and only comprehensive, full-body...
Arterys Receives First FDA Clearance for Oncology Imaging Suite With Deep Learning
Technology | Artificial Intelligence | February 15, 2018
Arterys Inc. announced its fifth 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Arterys...
Planmed Launches Improved Planmed Verity CBCT Scanner
Technology | Computed Tomography (CT) | February 07, 2018
Planmed announced the launch of the improved Planmed Verity cone beam computed tomography (CBCT) scanner for orthopedic...
Overlay Init